SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 102 filers reported holding SYROS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 7.90 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $23,000 | -62.9% | 19,109 | +0.5% | 0.00% | – |
| Q4 2021 | $62,000 | -36.1% | 19,016 | -12.9% | 0.00% | – |
| Q3 2021 | $97,000 | -2.0% | 21,843 | +19.9% | 0.00% | – |
| Q2 2021 | $99,000 | +17.9% | 18,214 | +62.9% | 0.00% | – |
| Q1 2021 | $84,000 | -84.3% | 11,178 | -87.6% | 0.00% | – |
| Q1 2020 | $534,000 | -33.3% | 90,013 | +16.6% | 0.00% | – |
| Q3 2019 | $801,000 | – | 77,214 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 881,450 | $5,677,000 | 1.32% |
| IFP Advisors, Inc | 50 | $1,000 | 0.00% |
| Ten Capital Wealth Advisors, LLC | 219 | $1,000 | 0.00% |